Life Science Entrepreneurism ~ Biotech Consulting
Whoriskey Associates works with high integrity people to assist in the building of companies to bring drugs and technologies that make a difference to the marketplace.
Prior to starting her consulting firm, Susan helped grow two biotech companies from their infancy to deliver on things she cares deeply about: the need for life saving drugs and safe, affordable medicines. Cubist Pharmaceuticals (CBST) and Momenta Pharmaceuticals (MNTA) each achieved successful public offerings, significant investor returns and the successful filing with the FDA of drugs for marketing approval. Cubicin was one of only two new chemical classes of antibiotics approved in the last 50 years and has been used to treat an estimated 750,000 seriously ill patients to date. Cubist was recently named the #1 company on the Globe100 publically traded companies list based upon the success of Cubicin. Momenta’s drug applications are currently under FDA review, pending approval.
The companies today have a combined value of over $1.5 billion and employ an estimated 650 people.
Whoriskey Associates can accelerate company building by facilitating:
- Scientific and business due diligence
- Clarification of vision and mission
- Formulation and articulation of business strategy, operational plan, and roadmap for future financings
- Definition of intellectual property strategies
- Negotiation and execution of academic, biotech and pharmaceutical collaborations
- Recruitment of Board of Directors, senior executives and employee base
